Trials / Completed
CompletedNCT03819088
Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer
Effects on QOL When Zinc is Supplemented in Patients With Upper GI Cancer on Chemotherapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Emory University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This randomized study examines how well zinc works in improving quality of life in patients with gastrointestinal cancer that cannot be removed by surgery who are receiving chemotherapy. Zinc may help to improve patient's quality of life by preventing zinc deficiency.
Detailed description
PRIMARY OBJECTIVE: I. Assess the effects on quality of life (QOL) when supplementing zinc in upper gastrointestinal (GI) cancer patients while they are receiving chemotherapy. SECONDARY OBJECTIVES: I. Correlate hypoalbuminemia with serum zinc deficiency. II. Correlate zinc deficiency with neutropenia. OUTLINE: Patients are randomized into 1 of 2 groups. GROUP I: Patients receive zinc orally (PO) thrice daily (TID) for months 1 and 2 only of the first 4 months on therapy. GROUP II: Patients receive zinc orally (PO) TID for months 3 and 4 only of the first 4 months on therapy.
Conditions
- Gastric Carcinoma
- Liver and Intrahepatic Bile Duct Carcinoma
- Unresectable Esophageal Carcinoma
- Unresectable Pancreatic Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Zinc | Given PO |
Timeline
- Start date
- 2019-04-17
- Primary completion
- 2021-10-05
- Completion
- 2022-03-22
- First posted
- 2019-01-28
- Last updated
- 2025-10-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03819088. Inclusion in this directory is not an endorsement.